These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2435245

  • 1. [Combination chemotherapy of urothelial cancer with cisplatin, cyclophosphamide, doxorubicin and peplomycin: treatment of advanced cases and adjuvant chemotherapy after radical operation].
    Seguchi T, Sakaguchi H, Kajikawa H, Nishioka T.
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):600-5. PubMed ID: 2435245
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 3. [Intraarterial COMPA (cis-diammine-dichloroplatinum (II), vincristine, methotrexate, peplomycin, adriamycin) chemotherapy for bladder cancer].
    Tsujino S, Ito T, Aizawa T, Namiki K, Ohno Y, Yamamoto S, Ishibashi K, Miki M, Yamauchi T, Kawai T.
    Hinyokika Kiyo; 1992 Oct; 38(10):1101-7. PubMed ID: 1282770
    [Abstract] [Full Text] [Related]

  • 4. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
    Kuroda M, Kotake T.
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
    [Abstract] [Full Text] [Related]

  • 5. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer].
    Konami T, Wakabayashi Y, Kim T, Ishida A, Arai Y, Konishi T, Pak K, Takeuchi H, Tomoyoshi T, Watanabe J.
    Hinyokika Kiyo; 1989 Feb; 35(2):231-7. PubMed ID: 2472048
    [Abstract] [Full Text] [Related]

  • 6. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
    Uekado Y, Ogawa T, Yoshida T, Yamamoto S, Hirano A, Watanabe T, Shinka T, Ohkawa T.
    Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
    [Abstract] [Full Text] [Related]

  • 7. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
    Yamauchi T, Hida S, Ooishi K, Okada K, Yoshida O.
    Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
    [Abstract] [Full Text] [Related]

  • 8. Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
    Yoshida O, Kakehi Y, Arai Y, Tomoyoshi T, Okada Y, Matsuda T, Mikami O, Fukuyama T, Hida S, Okabe T.
    Int J Urol; 1995 Nov; 2(5):316-21. PubMed ID: 8749950
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic experience of advanced urothelial tract tumors.
    Nakada T, Akiya T, Yoshikawa M, Umeda K, Katayama T.
    Hinyokika Kiyo; 1985 Apr; 31(4):601-6. PubMed ID: 4041118
    [Abstract] [Full Text] [Related]

  • 10. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.
    Sugiyama T, Nishida T, Hasuo Y, Fujiyoshi K, Yakushiji M.
    Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820
    [Abstract] [Full Text] [Related]

  • 11. [Results of combination chemotherapy in advanced urothelial cancer].
    Komatsubara S, Watanabe M, Kitamura Y, Sakata Y.
    Hinyokika Kiyo; 1988 Oct; 34(10):1697-702. PubMed ID: 3245518
    [Abstract] [Full Text] [Related]

  • 12. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Oct; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 13. [Cancer of the maxillary antrum--a new multidisciplinary treatment containing neo-adjuvant chemotherapy].
    Inuyama Y, Fujii M, Tnaka J, Takaoka T, Hosoda H, Kohno N.
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1165-73. PubMed ID: 6203487
    [Abstract] [Full Text] [Related]

  • 14. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
    Oshita F, Kasai T, Kurata T, Fukuda M, Yamamoto N, Ohe Y, Tamura T, Eguchi K, Shinkai T, Saijo N.
    Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
    [Abstract] [Full Text] [Related]

  • 15. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    Lehmann J, Franzaring L, Thüroff J, Wellek S, Stöckle M.
    BJU Int; 2006 Jan; 97(1):42-7. PubMed ID: 16336326
    [Abstract] [Full Text] [Related]

  • 16. Intensive chemotherapy for anaplastic thyroid carcinoma: combination of cisplatin, doxorubicin, etoposide and peplomycin with granulocyte granulocyte colony-stimulating factor support. Chemotherapy Committee, The Japanese Society of Thyroid Surgery.
    Jpn J Clin Oncol; 1995 Oct; 25(5):203-7. PubMed ID: 7474408
    [Abstract] [Full Text] [Related]

  • 17. [Neoadjuvant chemotherapy using methotrexate and cisplatin in locally advanced urothelial cancer of the bladder].
    Pizzocaro G, Piva L, Minervini G, Dormia E, Maggioni A, Mandressi A, Pisani E.
    Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):231-5. PubMed ID: 2142806
    [Abstract] [Full Text] [Related]

  • 18. [Combination chemotherapy with ifosfamide (or cyclophosphamide), adriamycin, cis-platinum and peplomycin (IAPP) for hormonally resistant metastatic prostatic cancer].
    Maeda O, Saiki S, Kinouchi T, Kuroda M, Miki T, Usami M, Kotake T.
    Hinyokika Kiyo; 1991 Dec; 37(12):1657-62. PubMed ID: 1723841
    [Abstract] [Full Text] [Related]

  • 19. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 20. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Oct; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.